Propanc Biopharma, Inc. (PPCB)

NASDAQ: PPCB · Real-Time Price · USD

3.670

-2.180 (-37.26%)

At close: Aug 19, 2025, 4:00 PM

4.130

+0.460 (12.52%)

After-hours: Aug 19, 2025, 7:59 PM EDT

Propanc Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 19, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2016 - 2020
Market Capitalization	46	0	1	0	-	-	Upgrade
Market Cap Growth	27582.21%	-25.62%	26.73%	-	-	-	Upgrade
Enterprise Value	47	1	1	1	-	-	Upgrade
Last Close Price	3.67	74.85	8083.83	220059.88	3095808.38	3900.00	Upgrade
PB Ratio	2.36	-0.11	-0.18	-0.15	-	-	Upgrade
Debt / Equity Ratio	0.07	-0.25	-0.17	-0.34	-0.22	-0.45	Upgrade
Quick Ratio	0.01	0.01	0.00	0.00	0.00	0.02	Upgrade
Current Ratio	2.24	0.01	0.01	0.01	0.00	0.02	Upgrade
Return on Assets (ROA)	-298.55%	-1447.01%	-1564.19%	-2626.42%	-2029.40%	-2182.06%	Upgrade
Earnings Yield	-119.70%	-438.79%	-476.99%	-603.95%	-	-	Upgrade
FCF Yield	-1.38%	-225.39%	-198.15%	-326.34%	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.